Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls

Surgical Oncology Clinics of North America
Monica Morrow

Abstract

Magnetic resonance imaging (MRI) is able to visualize small tumor deposits that previously could only be identified on pathologic examination. MRI is most valuable in areas in which patient management has been problematic, including screening women with known or suspected BRCA 1 and 2 mutations, and identification of the primary tumor site in patients presenting with axillary adenopathy. The role of MRI in the patient with newly diagnosed breast cancer remains controversial. Success rates for patients selected for breast-conserving therapy without MRI are high, and rates of ipsilateral breast tumor recurrence are low. Future efforts to improve the local therapy for breast cancer must acknowledge the heterogeneity of the disease and tailor approaches to the biology of individual subsets. This goal can only be accomplished through a multidisciplinary approach that examines the applications of newer diagnostic modalities such as MRI.

References

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M KurtzJ M Spitalier
Oct 1, 1989·International Journal of Radiation Oncology, Biology, Physics·A FourquetJ R Vilcoq
Jul 1, 1986·American Journal of Surgery·M M KemenyJ R Benfield
Feb 1, 1986·Cancer·P I Pressman
Jun 15, 1980·Cancer·G F SchwartzA B Schwartz
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I GageJ L Connolly
Mar 24, 1998·Journal of the American College of Surgeons·M MorrowA Rademaker
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L MarianiU Veronesi
Apr 22, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G van TienhovenJ A van Dongen
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A FortinD Tremblay
Dec 11, 1999·JAMA : the Journal of the American Medical Association·K KerlikowskeS R Cummings
Jul 14, 2000·Annals of Surgical Oncology·J A OlsonP I Borgen
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C T BrekelmansUNKNOWN Rotterdam Committee for Medical and Genetic Counseling
May 18, 2001·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·G Noël, J J Mazeron
Mar 21, 2003·AJR. American Journal of Roentgenology·Laura LibermanLee K Tan
May 3, 2003·Lancet·Suzie J OttoUNKNOWN National Evaluation Team for Breast Cancer Screening
Jun 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Xiang GaoBahman Emami
Jan 21, 2004·The Breast : Official Journal of the European Society of Mastology·B Salvadori, U Veronesi
Feb 14, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M F ErnstJ A Roukema
Jul 30, 2004·The New England Journal of Medicine·Mieke KriegeUNKNOWN Magnetic Resonance Imaging Screening Study Group
Sep 16, 2004·JAMA : the Journal of the American Medical Association·Ellen WarnerSteven A Narod
Sep 24, 2004·AJR. American Journal of Roentgenology·Francesco SardanelliUNKNOWN Italian Trial for Breast MR in Multifocal/Multicentric Cancer
Jan 26, 2005·International Journal of Radiation Oncology, Biology, Physics·Sharon GalperJay R Harris
Sep 20, 2005·The New England Journal of Medicine·Etta D PisanoUNKNOWN Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group
Oct 26, 2005·Annals of Surgical Oncology·Claire L BuchananKimberly J Van Zee
Oct 28, 2005·The New England Journal of Medicine·Donald A BerryUNKNOWN Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christiane K KuhlHans H Schild
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irene L WapnirNorman Wolmark

❮ Previous
Next ❯

Citations

Dec 7, 2013·Breast Cancer Research and Treatment·Alice K Fortune-GreeleyWilliam R Carpenter
Dec 5, 2012·Annals of Surgical Oncology·Brigid K KilleleaAnees B Chagpar
Dec 12, 2012·Annals of Surgical Oncology·Melissa PilewskieSeema A Khan
Aug 27, 2013·Annals of Surgical Oncology·Oluwadamilola M FayanjuJulie A Margenthaler
Jul 31, 2013·The Journal of Surgical Research·Oluwadamilola M FayanjuJulie A Margenthaler
Jun 11, 2011·The Journal of Surgical Research·Courtney A SommerTimothy S Carey
Dec 28, 2010·The Surgical Clinics of North America·Jeffrey Landercasper, Jared H Linebarger
Sep 25, 2015·The Breast Journal·Melissa PilewskieMary L Gemignani
Nov 30, 2011·Current Opinion in Obstetrics & Gynecology·John H Howard, Kirby I Bland
Sep 3, 2016·Experimental and Therapeutic Medicine·Huiyu ZhangYan Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.